Coordinated regulation of osmotic imbalance by c-di-AMP shapes ß-lactam tolerance in Group B

Terry Brissac,Cécile Guyonnet,Aymane Sadouni,Ariadna Hernandez Montoya,Elise Jacquemet,Rachel Legendre,Odile Sismeiro,Patrick Trieu-Cuot,Philippe Lanotte,Asmaa Tazi,Arnaud Firon

DOI: https://doi.org/10.1101/2024.03.27.586946

2024-03-27

Abstract:is among the few pathogens that have not developed resistance to ß-lactam antibiotics despite decades of clinical use. The molecular basis of this long-lasting susceptibility has not been investigated, and it is not known whether specific mechanisms constrain the emergence of resistance. In this study, we report the conserved role of the signaling nucleotide cyclic-di-AMP in susceptibility to ß-lactams, demonstrating that inactivation of the phosphodiesterase GdpP in confers ß-lactam tolerance. Characterization of the c-di-AMP signaling pathway reveals antagonistic regulation by the transcriptional factor BusR, which is activated by c-di-AMP and negatively regulates ß-lactam susceptibility through the BusAB transporter and AmaP/Asp23 cell envelope stress complex. Furthermore, we show that the simultaneous inhibition of osmolyte transporters activity and transcription by c-di-AMP has an additive effect, sustaining ß-lactam tolerance. Finally, we expanded the analysis of ß-lactam tolerance using random transposon mutagenesis, uncovering a convergent pattern of mutations involving the KhpAB small RNA chaperone and the S protein immunomodulator. Overall, our results demonstrate that c-di-AMP acts as a turgor pressure rheostat, coordinating an integrated response to cell wall weakening due to ß-lactam activity, and identify mechanisms that may foster antibiotic resistance in .

Microbiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how the signaling nucleotide c - di - AMP regulates osmotic imbalance in Group B Streptococcus (GBS), thereby affecting the tolerance to β - lactam antibiotics. Although GBS has long been sensitive to β - lactam antibiotics, its molecular basis has not been deeply studied. Through research, the authors found that c - di - AMP negatively regulates β - lactam sensitivity by activating the transcription factor BusR, especially through the actions of the BusAB transporter and the AmaP/Asp23 cell wall stress complex. In addition, c - di - AMP simultaneously inhibits the activity and transcription of osmotic pressure transporters, and this dual effect enhances the tolerance to β - lactam. The paper also reveals the mutation patterns involving the KhpAB small RNA chaperone and the S - protein immunomodulator through random transposon mutation analysis, and these mechanisms may promote the development of GBS antibiotic resistance.

In summary, this study aims to clarify how c - di - AMP acts as an osmotic pressure regulator to coordinate the overall response when the cell wall is weakened and to identify the mechanisms that may promote the development of GBS antibiotic resistance. This not only helps to understand why GBS has long remained sensitive to β - lactam antibiotics, but also provides a new perspective for preventing and controlling the emergence of antibiotic resistance.